GEIPE Answers to Questions That FTC & FDA Want Cancer Patients to Ask

American Federal Trade Commission (FTC) works with Food & Drug Administration (FDA) and wants patients to ask certain questions before deciding whether to avail a health-related product or therapy:

Those questions along with answers of Non-Invasive GEIPE treatment are provided below:

Question 1. What is in the product; what does this therapy entail?

Answer: The GEIPE cancer treatment involves low-level direct current electrotherapy. We provide the device, along with instructions. Patients to make/buy appropriate custom electrodes of aluminum-or-steel sheet and cloth. We provide these electrodes initially, and can get them made subsequently. Non-invasive form of GEIPE is almost like a home remedy and needs to be applied in the time-range of 4 hours per day for 2-3 weeks to 8 hours per day for 8 to 10 weeks, depending on the size, location and nature of the tumor. .

Question 2. What is the evidence that this product/therapy will do whatever the product/therapy purports to do (e.g., counteract the disease or medical condition being treated; relieve symptoms or side effects; lead to better results than conventional treatment)? 

Answer: Please see the "Patients Treated with GEIPE Therapy" link of the website for information about four recently treated patients. The Struggle” page of the web site gives reasons why cancer institutions have not taken initiative to do clinical trials of this treatment. Please also read “Cancer Cure?” page of the web site.

Patients may want to see the following few links which further boost the validity of GEIPE principle & treatment:

https://www.webmd.com/cancer/brain-cancer/news
(FDA Approves Device that uses electrical fields for Brain Tumor Treatment)

https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/treating
(Alternating Electric Field Therapy for Adult Brain and Spinal Cord Tumors)

https://pubmed.ncbi.nlm.nih.gov/16545779/
(Nanosecond pulsed electric fields destroy melanomas)

http://www.technologyreview.com/biotech/19195/
(Electric Fields Kill Tumors)

Question 3. Have results from studies of this product/therapy been published in any peer-reviewed medical journals? Can I have copies of the publications or references to these publications?

Answer: Yes. The “Scientific Publications” page of the web site has links to the 3 peer-reviwed scientific articles on the subject. The first one documents 10 scientific studies, 3 of which had very positive results with gentle electrotherapy. (Other 7 studies used parameters outside the GEIPE therapy range.) The most positive of these was a 1985 scientific study published in esteemed journal Cancer Research reporting 98% reduction in tumor mass in 5 hr. treatment over 5 days. The second one describes how GEIPE treatment was able to heal two human cancer patients. The last one is a review article published in 2023: Biochemistry – Not Oncogenes – May Demystify and Defeat Cancer.

Question 4. How will I know that the product/therapy is or is not working?

Answer: After 1-2 weeks of GEIPE therapy, you should notice arrest of further growth of tumor and attendant relief. Some patients notice the difference in a matter of days.

Question 5. What is the evidence that the product/therapy is safe? Are there potential side effects?

Answer: Direct Current electricity at such low-levels is deemed to be safe. For example, most major manufacturers of electrotherapy electrodes include an advisory with their electrodes that patients should not exceed 0.1 watts/cm2. Current and voltage levels employed with GEIPE treatment will generate about one-hundredths (1/100th) of this limit.

We are not aware of any potential side effects. If patients notice some adverse reaction that correlates with GEIPE treatment, they should immediately stop the treatment and inform us of the circumstances.

Question 6. Are there potential interactions with prescription medications?

Answer: We are not aware of any. No studies have been done in this area.

Question 7. What are the training and credentials of the provider?

Answer: Please see “About Us” page of the web site.

Question 8. Is the provider willing to communicate with my primary care physician and/or my health insurance company? 

Answer: Yes, certainly.

Last updated: May 28, 2021

ddd